Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil M Richtand

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Psychiatry Research|August 22, 2008
Deficits in docosahexaenoic acid and associated elevations in the metabolism of arachidonic acid and saturated fatty acids in the postmortem orbitofrontal cortex of patients with bipolar disorderRobert K McNamara, Ronald Jandacek, Therese Rider, et al.
Synapse (New York, N.Y.)|July 25, 2008
Omega-3 fatty acid deficiency augments amphetamine-induced behavioral sensitization in adult DBA/2J mice: relationship with ventral striatum dopamine concentrationsRobert K McNamara, Juliana Sullivan, Neil M Richtand, et al.
Biological Psychiatry|December 26, 2006
Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorderRobert K McNamara, Chang-Gyu Hahn, Ronald Jandacek, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 26, 2007
Dopamine and serotonin receptor binding and antipsychotic efficacyNeil M Richtand, Jeffrey A Welge, Aaron D Logue, et al.
Schizophrenia Research|January 24, 2007
Abnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: gender differences and partial normalization with antipsychotic medicationsRobert K McNamara, Ronald Jandacek, Therese Rider, et al.
Progress in Brain Research|September 6, 2008
Role of serotonin and dopamine receptor binding in antipsychotic efficacyNeil M Richtand, Jeffrey A Welge, Aaron D Logue, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 24, 2002
7-OH-DPAT and PD 128907 selectively activate the D3 dopamine receptor in a novel environmentLaurel M Pritchard, Aaron D Logue, Scott Hayes, et al.
Neurotoxicology and Teratology|December 3, 2014
Prenatal immune challenge in rats: effects of polyinosinic-polycytidylic acid on spatial learning, prepulse inhibition, conditioned fear, and responses to MK-801 and amphetamineCharles V Vorhees, Devon L Graham, Amanda A Braun, et al.
Synapse (New York, N.Y.)|April 5, 2012
Prenatal immune challenge in rats: altered responses to dopaminergic and glutamatergic agents, prepulse inhibition of acoustic startle, and reduced route-based learning as a function of maternal body weight gain after prenatal exposure to poly ICCharles V Vorhees, Devon L Graham, Amanda A Braun, et al.
Brain Research Bulletin|October 10, 2006
Relative expression of D3 dopamine receptor and alternative splice variant D3nf mRNA in high and low responders to noveltyLaurel M Pritchard, Aaron D Logue, Benjamin C Taylor, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Psychiatry Research|August 22, 2008
Deficits in docosahexaenoic acid and associated elevations in the metabolism of arachidonic acid and saturated fatty acids in the postmortem orbitofrontal cortex of patients with bipolar disorderRobert K McNamara, Ronald Jandacek, Therese Rider, et al.
Synapse (New York, N.Y.)|July 25, 2008
Omega-3 fatty acid deficiency augments amphetamine-induced behavioral sensitization in adult DBA/2J mice: relationship with ventral striatum dopamine concentrationsRobert K McNamara, Juliana Sullivan, Neil M Richtand, et al.
Biological Psychiatry|December 26, 2006
Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorderRobert K McNamara, Chang-Gyu Hahn, Ronald Jandacek, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 26, 2007
Dopamine and serotonin receptor binding and antipsychotic efficacyNeil M Richtand, Jeffrey A Welge, Aaron D Logue, et al.
Schizophrenia Research|January 24, 2007
Abnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: gender differences and partial normalization with antipsychotic medicationsRobert K McNamara, Ronald Jandacek, Therese Rider, et al.
Progress in Brain Research|September 6, 2008
Role of serotonin and dopamine receptor binding in antipsychotic efficacyNeil M Richtand, Jeffrey A Welge, Aaron D Logue, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 24, 2002
7-OH-DPAT and PD 128907 selectively activate the D3 dopamine receptor in a novel environmentLaurel M Pritchard, Aaron D Logue, Scott Hayes, et al.
Neurotoxicology and Teratology|December 3, 2014
Prenatal immune challenge in rats: effects of polyinosinic-polycytidylic acid on spatial learning, prepulse inhibition, conditioned fear, and responses to MK-801 and amphetamineCharles V Vorhees, Devon L Graham, Amanda A Braun, et al.
Synapse (New York, N.Y.)|April 5, 2012
Prenatal immune challenge in rats: altered responses to dopaminergic and glutamatergic agents, prepulse inhibition of acoustic startle, and reduced route-based learning as a function of maternal body weight gain after prenatal exposure to poly ICCharles V Vorhees, Devon L Graham, Amanda A Braun, et al.
Brain Research Bulletin|October 10, 2006
Relative expression of D3 dopamine receptor and alternative splice variant D3nf mRNA in high and low responders to noveltyLaurel M Pritchard, Aaron D Logue, Benjamin C Taylor, et al.
Pageof 4